1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Xu, Y.
Wu, J.
Pei, J.
Shi, Y.
Ji, Y.
Tong, Q.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
13669
13675
10.1021/bi000860s
11076505
Solution structure of BmP02, a new potassium channel blocker from the venom of the Chinese scorpion Buthus martensi Karsch.
2000
10.2210/pdb1du9/pdb
pdb_00001du9
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2959.424
BMP02 NEUROTOXIN
1
nat
polymer
no
no
VGCEECPMHCKGKNAKPTCDDGVCNCNV
VGCEECPMHCKGKNAKPTCDDGVCNCNV
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Chinese scorpion
Mesobuthus
sample
34649
Mesobuthus martensii
VENOM
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2000-02-04
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
RCSB
Y
RCSB
2000-01-17
REL
REL
This structure was determined using standard 2D homonuclear techniques.
structures with the least restraint violations
50
25
2D NOESY
DQF-COSY
TOCSY
2D NOESY
DQF-COSY
TOCSY
0
4.0
1
atm
300
K
simulated annealing and ENERGY MINIMIZATION
1
minimized average structure
3mM BmP02; 90% H2O, 10% D2O
90% H2O/10% D2O
3mM BmP02; 100% D2O
100% D2O
BRUNGER
structure solution
CNSSOLVE
0.9a
BRUNGER
refinement
CNSSOLVE
0.9a
500
Bruker
DMX
VAL
1
n
1
VAL
1
A
GLY
2
n
2
GLY
2
A
CYS
3
n
3
CYS
3
A
GLU
4
n
4
GLU
4
A
GLU
5
n
5
GLU
5
A
CYS
6
n
6
CYS
6
A
PRO
7
n
7
PRO
7
A
MET
8
n
8
MET
8
A
HIS
9
n
9
HIS
9
A
CYS
10
n
10
CYS
10
A
LYS
11
n
11
LYS
11
A
GLY
12
n
12
GLY
12
A
LYS
13
n
13
LYS
13
A
ASN
14
n
14
ASN
14
A
ALA
15
n
15
ALA
15
A
LYS
16
n
16
LYS
16
A
PRO
17
n
17
PRO
17
A
THR
18
n
18
THR
18
A
CYS
19
n
19
CYS
19
A
ASP
20
n
20
ASP
20
A
ASP
21
n
21
ASP
21
A
GLY
22
n
22
GLY
22
A
VAL
23
n
23
VAL
23
A
CYS
24
n
24
CYS
24
A
ASN
25
n
25
ASN
25
A
CYS
26
n
26
CYS
26
A
ASN
27
n
27
ASN
27
A
VAL
28
n
28
VAL
28
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ASP
20
A
N
ASP
20
A
O
VAL
23
A
O
VAL
23
1
A
HIS
9
-58.49
-77.76
1
A
LYS
13
-157.18
-41.38
1
A
ASN
27
-128.28
-84.43
2
A
CYS
10
-177.50
123.88
2
A
ASN
27
-157.89
-85.43
3
A
GLU
5
-142.37
29.63
3
A
ASN
27
-147.25
-82.26
4
A
HIS
9
-83.68
-75.19
4
A
LYS
11
-174.34
115.62
4
A
LYS
13
-157.32
-32.03
4
A
ASN
27
-135.33
-86.17
5
A
CYS
10
55.61
104.28
5
A
LYS
13
-160.00
-42.04
5
A
ASN
27
-125.66
-81.81
6
A
LYS
13
-156.08
-40.87
6
A
ASN
27
-138.74
-86.69
7
A
ASN
14
-142.11
29.08
7
A
ALA
15
178.48
131.05
7
A
ASN
27
-132.90
-84.01
8
A
HIS
9
-71.75
-77.72
8
A
LYS
13
-160.21
-37.34
8
A
ASN
27
-127.35
-83.08
9
A
ASN
14
-140.43
29.21
9
A
ALA
15
-177.65
129.75
9
A
ASN
27
-127.18
-83.24
10
A
HIS
9
-80.49
-75.36
10
A
LYS
13
-155.18
-25.52
10
A
ALA
15
-176.03
128.75
10
A
ASN
27
-124.88
-82.16
11
A
HIS
9
-76.11
-77.49
11
A
LYS
13
-158.85
-41.23
11
A
ASN
27
-121.72
-88.99
12
A
CYS
10
56.78
-172.91
12
A
LYS
13
-161.02
-34.57
13
A
MET
8
-176.96
-40.61
13
A
LYS
13
-153.65
-25.07
13
A
ALA
15
-176.21
128.42
13
A
ASN
27
-138.37
-82.02
14
A
ASN
27
-143.50
-82.45
15
A
HIS
9
-71.91
-79.13
15
A
ASN
27
-149.30
-82.36
16
A
MET
8
179.14
-37.76
16
A
CYS
10
-170.57
-83.81
16
A
LYS
11
59.11
115.43
16
A
LYS
13
-162.70
-58.66
16
A
ASN
27
-151.05
-86.59
17
A
CYS
10
-150.25
88.37
17
A
ASN
27
-140.90
-82.48
18
A
LYS
13
-161.12
-30.67
18
A
ALA
15
-175.51
128.83
18
A
ASN
27
-125.27
-93.29
19
A
CYS
10
82.41
89.66
19
A
LYS
13
-160.67
-43.09
19
A
ASN
27
-137.98
-87.77
20
A
LYS
13
-162.50
-36.37
20
A
ASN
27
-129.86
-79.64
21
A
LYS
13
-163.14
-42.38
21
A
ASN
27
-126.32
-90.08
22
A
ASN
14
-141.28
28.90
22
A
ALA
15
-179.63
130.10
22
A
ASN
27
-120.64
-80.02
23
A
LYS
13
-151.87
-26.13
23
A
ASN
27
-121.42
-82.28
24
A
LYS
13
77.78
-14.56
24
A
ASN
27
-116.64
-81.22
25
A
LYS
13
77.70
-14.54
25
A
ASN
27
-147.45
-79.37
minimized average
SOLUTION STRUCTURE OF BMP02, A NATURAL SCORPION TOXIN WHICH BLOCKS APAMIN-SENSITIVE CALCIUM-ACTIVATED POTASSIUM CHANNELS, 25 STRUCTURES
1
N
N
A
GLU
5
A
GLU
5
HELX_P
A
CYS
10
A
CYS
10
1
1
6
disulf
2.030
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
19
A
SG
CYS
19
1_555
disulf
2.030
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
24
A
SG
CYS
24
1_555
disulf
2.031
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
26
A
SG
CYS
26
1_555
TOXIN
HELIX, SHEET, toxin
SCP2_MESMA
UNP
1
29
Q9NJP7
29
56
1DU9
1
28
Q9NJP7
A
1
1
28
2
anti-parallel
A
PRO
17
A
PRO
17
A
ASP
20
A
ASP
20
A
VAL
23
A
VAL
23
A
CYS
26
A
CYS
26
1
P 1